Contrast Media Injectors - EU Analysis and Market Forecasts

GlobalData
GLDATA56956
$4,450.00

Summary

Contrast media injectors are regularly used in radiology to inject contrast media agents into the bloodstream of patients in order to enable clear visualization of various pathologies. Contrast media injectors are used in hospitals in tandem with X-ray, CT, MRI and other scanners, and can be specialized by imaging device or designed for general compatibility. The market outlook for contrast media injectors is strongly driven by the increasing number of annual diagnostic systems across all diagnostic imaging modalities. This report will identify the unmet needs with current devices, discuss current and future technological trends, and analyse the contrast media injector market’s outlook by geography and segment. This report examines the contrast media injector market in six major European markets: France, Germany, Italy, Spain, Russia, and the UK.

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the European market. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions in using and evaluating the adoption of different types of contrast media injectors.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

- What is the current and future contrast media injector market outlook in Europe? What trends are affecting the European market?
- What is the competitive landscape and market share of major players in the contrast media injector space in Europe?
- What are the key, high growth markets that contrast media injector manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the contrast media injectors currently on the market? How will emerging technologies fulfill these unmet needs?
- What is physician perception and market outlook of contrast media injectors?
- What are the challenges and barriers that have hindered widespread adoption of contrast media injectors?

Reasons to buy

- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.


Companies Mentioned

Bayer AG
Bracco Diagnostics
Guerbet SA
ulrich GmbH & Co. KG
Nemoto Kyorindo

'

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Key Metrics in Major Markets
2.2 Market Dynamics
2.2.1 Technological Trends
2.2.2 Key Players
2.3 Global Market Future Outlook
2.4 What Do Physicians Think?
3 Introduction
3.1 Overview
3.1.1 CT Injectors
3.1.2 MRI Injectors
3.1.3 Angiographic Injectors
3.1.4 Safety Concerns
3.2 The Global Market
3.3 Catalyst
3.4 Related Reports
4 Market Access
4.1 Reimbursement
4.1.1 5EU and the Russian Federation
4.2 Regulatory Developments
4.3 M&A/Key Partnerships
5 Procedure Trends
5.1 Overview
5.1.1 Syringeless Injectors
5.1.2 Multidosing
5.1.3 Information Technology
5.1.4 Medical Tourism
6 Unmet Needs
6.1 Overview
6.1.1 Lower Initial Costs
7 Competitive Assessment
7.1 Company Share Analysis
7.1.1 5EU Market Share Analysis
7.2 Major Players
7.2.1 Bayer AG
7.2.2 Bracco Diagnostics
7.2.3 Guerbet SA
7.2.4 ulrich GmbH & Co. KG
7.2.5 Nemoto Kyorindo
7.2.6 Other Companies
7.3 Emerging Players
8 Market Outlooks
8.1 Market Drivers and Barriers
8.1.1 Driver: Workflow Optimization
8.1.2 Driver: Contrast Agent Waste Management
8.1.3 Driver: Imaging Systems
8.1.4 Driver: Patient Safety
8.1.5 Driver: Aging Populations
8.1.6 Barrier: Price Competition
8.1.7 Barrier: Manual Injectors
8.1.8 Barrier: OEM Partnerships
8.1.9 Barrier: Innovation
8.1.10 Barrier: Product Lifespan
8.2 Market Outlooks by Segment
8.2.1 CT Injectors
8.2.2 MRI Injectors
8.2.3 Angio Injectors
8.3 Market Outlooks by Geography
8.3.1 5EU and the Russian Federation Market Outlook
8.3.1.1 France Market Outlook
8.3.1.2 Germany Market Outlook
8.3.1.3 Italy Market Outlook
8.3.1.4 Spain Market Outlook
8.3.1.5 UK Market Outlook
8.3.2 Russian Federation Market Outlook
9 Appendix
9.1 Bibliography
9.2 Abbreviations
9.3 Methodology
9.3.1 Overview
9.3.2 Coverage
9.3.3 Physician Survey
9.3.4 Expert Panel Validation
9.3.5 Secondary Research
9.4 Forecasting Methodology
9.5 Primary Research Efforts
9.6 About the Authors
9.6.1 Sarah Janer, Analyst- Medical Devices
9.6.2 David Brady, Director of Operations - Market Research
9.6.3 Tyler Fletcher, Global Head of Medical Devices
9.7 About GlobalData
9.8 Contact Us
9.9 Disclaimer

1.1 List of Tables
Table 1: Contrast Media Injectors Key Metrics: Key Events and Pipeline Assessment
Table 2: 5EU and the Russian Federation Reimbursement Agencies
Table 3: Contrast Media Injectors Regulatory Issues and Recalls
Table 4: Mergers and Acquisitions
Table 5: Company profile - Bayer AG
Table 6 : Bayer AG’s Featured Contrast Injector Models
Table 7: SWOT Analysis - Bayer AG
Table 8: Company profile - Bracco S.p.A.
Table 9: Bracco S.p.A.’s Featured Contrast Injector Models
Table 10: SWOT Analysis - Bracco S.p.A.
Table 11: Company profile - Guerbet SA
Table 12: Guerbet SA’s Featured Contrast Injector Models
Table 13: SWOT Analysis - Guerbet SA
Table 14: Company profile - ulrich GmbH & Co. KG
Table 15: ulrich GmbH & Co. KG’s Featured Contrast Injector Models
Table 16: SWOT Analysis - ulrich Gmbh & Co. KG
Table 17: Company profile - Nemoto Kyorindo
Table 18: Nemoto Kyorindo’s Featured Contrast Injector Models
Table 19: SWOT Analysis - Nemoto Kyorindo
Table 20: Other Contrast Media Injector Companies
Table 21: Angiodroid America Inc.’s Featured Contrast Injector Models
Table 22: SWOT Analysis - Angiodroid America
Table 23: AngioDynamics Featured Contrast Injector Models
Table 24: SWOT Analysis - AngioDynamics
Table 25: Apollo RT Co., Limited’s Featured Contrast Injector Models
Table 26: SWOT Analysis - Apollo RT Co., Limited
Table 27: Global Market Value Forecast for Contrast Media Injectors $M, 2012-2022
Table 28: Global Market Value Forecast for CT Injectors, $M, 2012-2022
Table 29: Global Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 30: Global Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 31: 5EU and Russian Federation Market Value Forecast for All Segments $M, 2012-2022
Table 32: France Market Volume Forecast by Segment, 2012-2022
Table 33: France Market Value Forecast for CT Injectors, $M, 2012-2022
Table 34: France Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 35: France Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 36: Germany Market Volume Forecast by Segment, 2012-2022
Table 37: Germany Market Value Forecast for CT Injectors, $M, 2012-2022
Table 38:Germany Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 39: Germany Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 40: Italy Market Volume Forecast by Segment, 2012-2022
Table 41: Italy Market Value Forecast for CT Injectors, $M, 2012-2022
Table 42: Italy Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 43: Italy Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 44: Spain Market Volume Forecast by Segment, 2012-2022
Table 45: Spain Market Value Forecast for CT Injectors, $M, 2012-2022
Table 46: Spain Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 47: Spain Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 48: UK Market Volume Forecast by Segment, 2012-2022
Table 49: UK Market Value Forecast for CT Injectors, $M, 2012-2022
Table 50: UK Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 51: UK Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 52: Russian Federation Market Volume Forecast by Segment, 2012-2022
Table 53: Russian Federation Market Value Forecast for CT Injectors, $M, 2012-2022
Table 54: Russian Federation Market Value Forecast for MRI Injectors, $M, 2012-2022
Table 55: Russian Federation Market Value Forecast for Angio Injectors, $M, 2012-2022
Table 56: Physicians Surveyed, By Country
Table 57: Primary Research Interviews Completed

1.2 List of Figures
Figure 1: Contrast Media Global Market Share Comparison by Major Market, 2015 and 2022 Forecast
Figure 2: Automatic and Manual Contrast Media Injectors
Figure 3: Types of CT Injectors by Syringe Model
Figure 4: Effect of a Saline Chaser on the Radio density of an Iodine Contrast Agent
Figure 5: Cerebral Angiography of Arteria Vertebralis, Sinister Injection
Figure 6: Global Contrast Media Injector Revenue Market Share 2015
Figure 7: Global Market Share of the Contrast Media Injector Market in 2015 (%)
Figure 8: 5EU Market Share of the Contrast Media Injector Market in 2015 (%)
Figure 9 : Average Number of Contrast Media Injectors Sold Per Diagnostic Imaging Device Type in 2016
Figure 10: Manual Contrast Injector and Power Contrast Injector Use by Country 2015
Figure 11: Global Market Value Forecast by Market Segment for Contrast Media Injectors, $m, 2012-2021
Figure 12: Global Market Value Forecast for Single and Dual Head Injectors, $M, 2012-2022
Figure 13: Global Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 14: Global Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 15: 5EU and Russian Federation Market Value Forecast by Market Segment for Contrast Media Injectors, $M, 2012-2022
Figure 16: France Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 17: France Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 18: France Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 19: France Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 20: Germany Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 21: Germany Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 22: Germany Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 23: Germany Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 24: Italy Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 25: Italy Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 26: Italy Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 27: Italy Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 28: Spain Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 29: Spain Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 30: Spain Market Value Forecast by Market Segment for MRI Injectors, $M, 2012-2022
Figure 31: Spain Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 32: UK Market Volume by Market Segment for Contrast Media Injectors, %, 2015
Figure 33: UK Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 34: UK Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 35: UK Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022
Figure 36: Russian Federation Market Volume by Segment for Contrast Media Injectors, %, 2015
Figure 37: Russian Federation Market Value Forecast by Market Segment for CT Injectors, $M, 2012-2022
Figure 38: Russian Federation Market Value Forecast by Market Segment for CT Injectors, $M, 20122022
Figure 39: Russian Federation Market Value Forecast by Market Segment for Angio Injectors, $M, 2012-2022

$4,450.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838